Latest News

Drug company recalls birth control pills after placebo tablets were placed in the wrong spots

By Mason White 2:00 PM June 9, 2017
Mibelas 24 Fe birth control pills
Mibelas 24 Fe birth control pills
By: Alexis Bell

(Scroll down for video) A drug company announced a recall of birth control pills after some of them might cause unintended pregnancies, according to a press release by the Food and Drug Administration (FDA).

Lupin Pharmaceuticals Inc. of Baltimore, Maryland, announced that it has voluntarily recalled lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets at the consumer level.

A confirmed market complaint indicated a packaging error, which reversed the weekly tablet orientation and made the lot number and expiration date no longer visible.

The first four days of therapy would have had four non-hormonal placebo tablets as opposed to the active pills.

As a result of this packaging error, oral contraceptive tablets that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy.

The reversing the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the tablets out of order.

This product is an oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives.

These products are packaged in packs containing 28 tablets, 24 white to off-white tablets of active ingredients debossed with “LU” on one side and “N81” on the other and 4 tablets of inert ingredients debossed with “LU” on one side and “M22” on the other side.

This product was distributed Nationwide in the U.S. to wholesalers, clinics and retail pharmacies.

Consumers who have the affected product should notify their physician and return the product to the pharmacy or place of purchase.